Clinical Trial Results: Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of 0.75% phentolamine ophthalmic solution for mesopic vision and night vision disturbances after refractive surgery…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mesopic Vision
• Night Vision Loss

Drugs mentioned

• 0.75% Phentolamine Ophthalmic Solution (phentolamine)

Snippet

Sponsor: Ocuphire Pharma, Inc. | Conditions: Mesopic Vision, Night Vision Loss | Phase 3 | Status: COMPLETED | Results posted: 2026-08-18